Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue
Abstract
Infantile hemangiomas (IH) are neoplastic proliferations of endothelial cells which occur with an incidence of 10 to 12% within the first year of life. IH grow after birth and usually regress spontaneously, but still can lead to deformities when they are located in the facial areas of the lip, eyelid, nasal tip or the ear. We wanted to share our experience in the treatment of problematic IH with propranolol. A retrospective review of medical charts was performed for 40 consecutive children treated with propranolol because of problematic IH between 2009 and 2012. 40 patients (33 girls, 7 boys) with a median age of 4.2 months (aged 1 to 11 months) were treated because of problematic IH. Rapid improvement was reported in the first days of treatment in 38 patients. In one case we had to terminate the treatment because serious tachycardia developed within the first 48 hours after propranolol was started. In this case the patient benefited from alternative treatment with timolol maleate gel. 35 patients (87%) showed an excellent response with complete resolution of the lesion. 4 patients (10%) showed a good result with >50% reduction in the size of the hemangioma. Also a patient with residual IH after terminating oral propranolol benefited from topical treatment with timolol maleate gel. A minor side effect was poor weight gain during prolonged treatment in one patient and tachycardia in another patient in which case we had to terminate the treatment. Conclusions: Our observations show that gradually increasing the dosage of propranolol up to 3 mg/kg and gradually weaning the dosage is safe and effective in treatment of problematic IH. Timolol maleate gel should be considered as a complementary treatment for residual hemangiomas after terminating propranolol treatment or as an alternative treatment in patients who do not tolerate oral propranolol well.
Authors and Affiliations
Marzanna Oksiuta, Ewa Matuszczak, Wojciech Dębek, Adam Hermanowicz, Marzena Tylicka
Keywords
Related Articles
- EP ID EP67484
- DOI -
- Views 140
- Downloads 0
Rola resweratrolu w regulacji metabolizmu komórkowego
Spożywanie wina w umiarkowanych ilościach wiąże się z obniżonym ryzykiem wystąpienia chorób sercowo-naczyniowych i mózgowo-naczyniowych, chorób naczyń obwodowych, a także nowotworów. Zjawisko to określa się mianem „franc...
KIM-1 i NGAL jako potencjalne biomarkery w diagnostyce i rozwoju procesu nowotworowego
Na podstawie przeglądu piśmiennictwa przedstawiono dane wskazujące, że KIM-1 i NGAL są interesującymi i obiecującymi biomarkerami nie tylko w ostrych i przewlekłych procesach zapalnych, lecz również w onkogenezie. Prowad...
Kwasy mikolowe – potencjalne markery diagnostyki oportunistycznych zakażeń mikroorganizmami z podrzędu Corynebacterineae
Kwasy mikolowe to jeden z podstawowych elementów budowy ściany komórkowej bakterii rzędu Actinomycetales, podrzędu Corynebacterineae. Pod względem taksonomicznym przynależy do nich wielu przedstawicieli oportunistycznyc...
Angiogenesis and immune supression: yin and yang of tumor progression?
Specialized variants of neoplastic cells that appear in tumors during cancer disease progression possess the ability to recruit certain kinds of hematopoietic and mesenchymal cells from the bone marrow or bloodstream. Th...
Synteza cytokin na poziomie komórkowym przez limfocyty T u myszy BALB/c i C57BL/6 zakażonych wirusem ektromelii
Wstęp: Przedmiotem pracy było określenie syntezy IFN-γ, IL-2, TNF-α (Th1/Tc1) oraz IL-4 (Th2/Tc2) na poziomie pojedynczych limfocytów T CD4+ i T CD8+ w przebiegu zakażenia myszy BALB/c i C57BL/6 szczepem Moscow wirusa e...